Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1164/AJRCCM.158.1.9709007PMID 9655712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation.

  1996cited by this paper
• Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema.

  1996cited by this paper
• Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome.

  1996cited by this paper
• Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia

  1995cited by this paper
• Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia.

  1995cited by this paper
• Beneficial cardiopulmonary effects of pentoxifylline in experimental sepsis are lost once septic shock is established.

  1994cited by this paper
• Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

  1994cited by this paper
• Endotoxin administration to humans primes alveolar macrophages for increased production of inflammatory mediators

  1994cited by this paper
• Human responses to bacterial endotoxin.

  1994cited by this paper
• Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.

  1994cited by this paper
• Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.

  1994cited by this paper
• Role of the coagulation system in ARDS.

  1994cited by this paper
• The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor.

  1993cited by this paper
• Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.

  1993cited by this paper
• Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration.

  1993cited by this paper
• Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation.

  1993cited by this paper
• Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.

  1992cited by this paper
• Pulmonary and oxygen transport effects of intravenously administered endotoxin in normal humans.

  1992cited by this paper
• Cytokines of the lung.

  1992cited by this paper
• Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome.

  1991cited by this paper
• Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

  1990cited by this paper
• Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome.

  1990cited by this paper
• Procoagulant (thromboplastin) activity in human bronchoalveolar lavage fluids is derived from alveolar macrophages.

  1990cited by this paper
• Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants.

  1990cited by this paper
• Activation of coagulation after administration of tumor necrosis factor to normal subjects.

  1990cited by this paper
• Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways

  1990cited by this paper
• Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.

  1988cited by this paper
• Role of enzymes mediating thrombosis and thrombolysis in lung disease.

  1988cited by this paper
• Regulation of the procoagulant activity within the bronchoalveolar compartment of normal human lung.

  1988cited by this paper
• The placental type plasminogen activator inhibitor, PAI 2

  1987cited by this paper
• Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.

  1987cited by this paper
• Intraluminal fibrosis in interstitial lung disorders.

  1986cited by this paper
• A fibrinolytic inhibitor of human alveolar macrophages. Induction with endotoxin.

  1985cited by this paper
• Adult respiratory-distress syndrome: changing concepts of lung injury and repair.

  1982cited by this paper
• A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma

  1982cited by this paper
• Rapid microanalysis of coagulation parameters by automated chromogenic substrated methods - application in neonatal patients.

  1982cited by this paper
• Structural alterations of lung parenchyma in the adult respiratory distress syndrome.

  1982cited by this paper

• Bronchoscopic Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage-induced Acute Respiratory Failure in MPO-ANCA Vasculitis: A Case Report

  2022cites this paper
• Role of lungs in the hemostasis system (review of literature).

  2021cites this paper
• Nonhuman primate species as models of human bacterial sepsis

  2019cites this paper
• THEREOF TO TREAT OR INHIBIT

  2017cites this paper
• Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies.

  2017cites this paper
• Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage

  2015cites this paper
• Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer

  2014cites this paper
• Inflammation and Acute Phase Proteins in Haemostasis

  2013cites this paper
• Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome

  2013cites this paper
• Systematic review of chimpanzee use in monoclonal antibody research and drug development: 1981-2010.

  2011cites this paper
• Systemic versus localized coagulation activation contributing to organ failure in critically ill patients

  2011cites this paper
• Interactions of Leukocytes and Coagulation Factors with the Vessel Wall

  2011cites this paper
• Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice.

  2010cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Sepsis-associated Dissemin Thromboembolic Disease Associated Disseminated Intravascular Coagulation a Coagulation And

  2010cites this paper
• The Role of the Coagulation and Fibrinolytic Pathway in Acute Lung Injury

  2009cites this paper
• A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome and pneumonia

  2009influential citation
• The coagulation system and pulmonary endothelial function in acute lung injury.

  2009cites this paper
• Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.

  2009cites this paper
• The Role of Bronchoalveolar Hemostasis in the Pathogenesis of Acute Lung Injury

  2008cites this paper
• Induction of apoptosis and absence of inflammation in rat lung after intratracheal instillation of multiwalled carbon nanotubes.

  2008cites this paper
• Antithrombin-III as an early prognostic factor in children with acute lung injury

  2007cites this paper
• Clinical and hemostatic responses to treatment in ventilator-associated pneumonia: Role of bacterial pathogens*

  2007cites this paper
• Rapid communication Monoclonal antibodies against chicken interleukin-6

  2006cites this paper
• Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage

  2006cites this paper
• Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia—A review

  2006cites this paper
• Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response

  2006cites this paper
• Early procoagulant shift in the bronchoalveolar compartment of patients with secondary peritonitis.

  2006cites this paper
• Compartmentalization of the inflammatory response in sepsis and SIRS.

  2006cites this paper
• Monoclonal antibodies against chicken interleukin-6.

  2006cites this paper
• Endogenous Tissue-Type Plasminogen Activator Is Protective during Escherichia coli-Induced Abdominal Sepsis in Mice1

  2006cites this paper
• This information is current as-Induced Abdominal Sepsis in Mice coli Escherichia Activator Is Protective during Endogenous Tissue-Type Plasminogen

  2006cites this paper
• The relationship between inflammation and the coagulation system.

  2006cites this paper
• Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure.

  2006cites this paper
• Cellular and Molecular Aspects of Pneumonia

  2006cites this paper
• Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS

  2006cites this paper
• Localized coagulation activation and fibrin deposition in critically ill patients

  2005cites this paper
• Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers

  2005cites this paper
• Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia

  2004cites this paper
• Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: impact of inadequate antimicrobial therapy

  2004cites this paper
• Immune-modulating effects of polyunsaturated fatty acids : focus on dihomo-G-linolenic acid

  2004cites this paper
• MASSIVE ALVEOLAR THROMBIN ACTIVATION IN PSEUDOMONAS AERUGINOSA-INDUCED ACUTE LUNG INJURY

  2004cites this paper
• Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions

  2004cites this paper
• Anticoagulant therapy for acute lung injury or pneumonia.

  2003cites this paper
• Anticoagulant therapy in acute lung injury

  2003cites this paper
• Tissue factor-dependent coagulation protease signaling in acute lung injury

  2003cites this paper
• Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia

  2003influential citation
• Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation.

  2002cites this paper
• Coagulation and Inflammation in Acute Lung Injury

  2002cites this paper
• Coagulation Abnormalities in Critical Illness

  2002cites this paper
• Tissue factor in experimental acute lung injury.

  2001cites this paper
• Interstitial lung disease induced by exogenous agents: factors governing susceptibility.

  2001influential citation
• Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons.

  2001cites this paper
• Expression of β‐defensin‐1 in chimpanzee (Pan troglodytes) airways

  2000cites this paper
• Relative Insufficiency of the Fibrinolytic System in Disseminated Intravascular Coagulation

  1999cites this paper
• Disseminated Intravascular Coagulation

  1999cites this paper
• Disseminated intravascular coagulation.

  1999cites this paper
• Interleukin-6 in Bacterial Infection and Sepsis: Innocent Bystander or Essential Mediator?

  1999cites this paper